High-grade glioma expert group

Date: 03/12/2010
Location: London, UK
The European Medicines Agency is holding this expert meeting to understand and discuss how anti-cancer medicines should be developed to treat children with high-grade glioma, a disease with a dismal prognosis and high unmet needs. Recent biological and clinical data, as well as experience from paediatric trials, is being discussed. Preliminary consequences for paediatric trials and further questions are being identified.

How useful was this page?

Add your rating